Beaird Harris Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-19
Closed -$206 746
2025
Q3
$206 Buy
+19
New +$186 ﹤0.01% 665
2024
Q4
Sell
-5
Closed -$96 529
2024
Q3
$96 Sell
5
-54
-92% -$1.12K ﹤0.01% 502
2024
Q2
$1.22K Hold
59
﹤0.01% 581
2024
Q1
$1.11K Hold
59
﹤0.01% 539
2023
Q4
$851 Hold
59
﹤0.01% 531
2023
Q3
$1.02K Hold
59
﹤0.01% 392
2023
Q2
$1.23K Hold
59
﹤0.01% 387
2023
Q1
$1.39K Hold
59
﹤0.01% 393
2022
Q4
$1.65K Sell
59
-8
-12% -$205 ﹤0.01% 605
2022
Q3
$2K Buy
67
+45
+205% +$1.36K ﹤0.01% 407
2022
Q2
$1K Sell
22
-45
-67% -$1.58K ﹤0.01% 378
2022
Q1
$2K Sell
67
-24
-26% -$821 ﹤0.01% 528
2021
Q4
$3K Buy
+91
New +$2.96K ﹤0.01% 538

Other funds holding OGN

Beaird Harris Wealth Management's OGN Position: Q4 2025 in Review

Beaird Harris Wealth Management sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 19 shares — an estimated $206 sold.

Beaird Harris Wealth Management first reported a position in OGN in Q4 2021 and held it in 13 quarters. The position peaked at $3K in Q4 2021. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Beaird Harris Wealth Management reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 19 Organon & Co shares in Q4 2025, an estimated $206.
  • Beaird Harris Wealth Management first reported a position in Organon & Co in Q4 2021 and held it in 13 quarters.
  • Beaird Harris Wealth Management's Organon & Co position peaked at $3K in Q4 2021.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Beaird Harris Wealth Management's 13F filing for Q4 2025, filed 23 Feb 2026.